Ticagrelor or Clopidogrel to reduce ischemic events after Percutaneous Coronary Intervention in chronic coronary syndrome in clopidogrel naive patient: the ALPHEUS Naive sub-study

被引：0
|
作者：
Manzo-Silberman, S. [1 ]
Cayla, G. [2 ]
Beygui, F. [3 ]
Range, G. [4 ]
Motovska, Z. [5 ]
Vicaut, E. [6 ]
Collet, J. P. [1 ]
Guedeney, P. [1 ]
El Kasty, M. [7 ]
Kerneis, M. [1 ]
Zeitouni, M. [1 ]
Filippi, E. [8 ]
Coste, P. [9 ]
Montalescot, G. [1 ]
Silvain, J. [10 ]
机构：
[1] Sorbonne Univ, Cardiol, Paris, France
[2] Nimes Caremeau Univ Hosp Ctr, Cardiol, Nimes, France
[3] Univ Hosp Caen, Cardiol, Caen, France
[4] Hosp Louis Pasteur Chartres, Cardiol, Chartres, France
[5] Charles Univ Prague, Cardiol, Prague, Czech Republic
[6] St Louis Univ Hosp, Fernand Widal APHP Site, Methodol & Statist, Paris, France
[7] Hosp Sud Francilien, Cardiol, Corbeil Essonnes, France
[8] Vannes Hosp Ctr Bretagne Atlant, Cardiol, Vannes, France
[9] CHU Bordeaux, Cardiol, Bordeaux, France
[10] Sorbonne Univ, Paris, France
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Omeprazole affects clopidogrel efficacy but not ischemic events in patients with acute coronary syndrome undergoing elective percutaneous coronary intervention
    REN Yi-hong
    ZHAO Ming
    CHEN Yun-dai
    CHEN Lian
    LIU Hong-bin
    WANG Yu
    SUN Zhi-jun
    CHEN Jin-song
    HUANG Ting-ting
    GUO Yu-song
    XIE Yong-jin
    WANG Chun-ya
    中华医学杂志（英文版）, 2011, (06) : 856 - 861
  • [22] Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
    Valgimigli, Marco
    Gragnano, Felice
    Branca, Mattia
    Franzone, Anna
    da Costa, Bruno R.
    Baber, Usman
    Kimura, Takeshi
    Jang, Yangsoo
    Hahn, Joo-Yong
    Zhao, Qiang
    Windecker, Stephan
    Gibson, Charles M.
    Watanabe, Hirotoshi
    Kim, Byeong-Keuk
    Song, Young Bin
    Zhu, Yunpeng
    Vranckx, Pascal
    Mehta, Shamir
    Ando, Kenji
    Hong, Sung Jin
    Gwon, Hyeon-Cheol
    Serruys, Patrick W.
    Dangas, George D.
    McFadden, Eugene P.
    Angiolillo, Dominick J.
    Heg, Dik
    Calabro, Paolo
    Juni, Peter
    Mehran, Roxana
    JAMA CARDIOLOGY, 2024, 9 (05) : 437 - 448
  • [23] Omeprazole affects clopidogrel efficacy but not ischemic events in patients with acute coronary syndrome undergoing elective percutaneous coronary intervention
    Ren Yi-hong
    Zhao Ming
    Chen Yun-dai
    Chen Lian
    Liu Hong-bin
    Wang Yu
    Sun Zhi-jun
    Chen Jin-song
    Huang Ting-ting
    Guo Yu-song
    Xie Yong-jin
    Wang Chun-ya
    CHINESE MEDICAL JOURNAL, 2011, 124 (06) : 856 - 861
  • [24] Net Clinical Benefits of Ticagrelor Compared With Clopidogrel in Asian Acute Coronary Syndrome Patients: A Plato Sub-Study
    Kang, Hyun-Jae
    Clare, Robert M.
    Gao, Runlin
    Himmelmann, Anders
    Held, Claes
    Wallentin, Lars
    James, Stefan
    Becker, Richard C.
    CIRCULATION, 2013, 128 (22)
  • [25] In-stent thrombosis when switching ticagrelor to clopidogrel after percutaneous coronary intervention
    Brice, Aaron E.
    Hernandez, Gabriel A.
    Sanchez, Mariluz
    Haynick, Marshall
    Mendoza, Cesar E.
    PLATELETS, 2017, 28 (03) : 305 - 309
  • [26] Ad Hoc Percutaneous Coronary Intervention After In-Laboratory High Dose Clopidogrel Loading for Clopidogrel-Naive Patients: Safe for All?
    Davlouros, Periklis
    Alexopoulos, Dimitrios
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (01): : 139 - 140
  • [27] The efficacy and safety of ticagrelor versus clopidogrel in elderly patients with acute coronary syndrome undergoing percutaneous coronary intervention
    那堃
    ChinaMedicalAbstracts(InternalMedicine), 2022, 39 (01) : 31 - 31
  • [28] Ticagrelor vs clopidogrel when coadministered with bivalirudin in patients with acute coronary syndrome undergoing percutaneous coronary intervention
    Li, Yang
    Li, Yi
    Qiu, Miaohan
    Xue, Yu
    Xu, Kai
    Han, Yaling
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2024, 8 (03)
  • [29] Ticagrelor vs. Clopidogrel After Complex Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease
    Xi, Ziwei
    Li, Jianan
    Qiu, Hong
    Guo, Tingting
    Wang, Yong
    Li, Yang
    Zheng, Jianfeng
    Dou, Kefei
    Xu, Bo
    Wu, Yongjian
    Qiao, Shubin
    Yang, Weixian
    Yang, Yuejin
    Gao, Runlin
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [30] THE UTILITY OF CLOPIDOGREL RELOADING FOR PATIENTS PRESENTING WITH ACUTE CORONARY SYNDROME WHO ARE ON CHRONIC CLOPIDOGREL THERAPY AND UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
    Syed, Asmir I.
    Mahmoudi, Michael
    Ben-Dor, Itsik
    Gaglia, Michael A.
    Collins, Sara D.
    Maluenda, Gabriel
    Gonzalez, Manuel
    Wakabayashi, Kohei
    Sardi, Gabriel
    Romaguera, Rafael
    Laynez, Anna
    Torguson, Rebecca
    Xue, Zhenyi
    Bernardo, Nelson
    Lindsay, Joseph
    Kent, Kenneth M.
    Satler, Lowell F.
    Suddath, William O.
    Pichard, Augusto D.
    Waksman, Ron
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E933 - E933
12345